Medical experts and stakeholders from patient advocacy groups are keen to point out how crucial it is to consider patients’ voice as an added value when conducting cancer clinical trials, whatever policy on cancer, national or EU-wide, will eventually be put together.
The governments should take full responsibility for the implementation of national cancer plans, which are a commitment toward people and not just a piece of paper, health expert Dr Tit Albreht told EURACTIV.com in an interview.
With increased powers, Health Commissioner-designate Stella Kyriakides is tasked with striking a difficult balance between making sure there is a steady supply of affordable medicines and ensuring that EU pharma industry remains a world leader in innov...
Chemotherapy may be avoided in about 70% of early-stage breast cancer patients, thus limiting chemotherapy to the 30% who can be predicted it will be beneficial for them, a study released on Sunday (3 June) shows.
Across the EU, we have seen positive results for breast cancer care as more women are being diagnosed and treated earlier, leading to higher survival rates. However, while the EU as a whole is making advancement, progress is not consistent across its territory, writes Cristian Silviu Bușoi.
A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).